Health Condition 1: null- Health patients without any comorbidities
Conditions
Interventions
Intervention1: Dexmedetomidine: Dexmedetomidine as an intravenous infusion at the rate of 0.4mcg/kg/hr from the beginning of induction of general anaesthesia till extubation
Control Intervention1: Pla
Sponsors
Tejesh CA
Eligibility
Inclusion criteria
Inclusion criteria: American Society of Anaesthesiologists (ASA)grade 1 and 2 Patients undergoing nasal surgery under general anaesthesia and requiring nasal packing after surgery
Exclusion criteria
Exclusion criteria: Known or suspected allergy to α2 adrenergic agonists. Use of monoamine oxidase inhibitors, adrenergic blocking agents or clonidine. Uncontrolled hypertension and Diabetes mellitus. Heart block greater than first degree. Cognitive impairment. Chronic use of antipsychotic medications. Kidney or liver disease. Body Mass index >=30kg/m² Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Emergence agitation assessed by Ricker sedation-agitation scaleTimepoint: Emergence agitation assessed by Ricker sedation-agitation scale immediately after extubation of the patient | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Time to verbal response and extubation 2.Introperative analgesic requirement 3.Duration of PACU stayTimepoint: 1.After patient awakening from anaesthesia 2.At the end of Intraoperative period 3.At the time of discharge from recovery room | — |
Countries
India
Contacts
Public ContactTejesh CA
MS Ramaiah Medical College
Outcome results
None listed